CM in patients with single anterior wall and LUS myomas does not cause increased perioperative morbidity, and, therefore, can be considered safe in such cases.
Infekcije urinarnog trakta su među najčešćim infekcijama u vanbolničkoj i bolničkoj sredini. Bolesnici oboleli od dijabetesa imaju češće urinarne infekcije, kao i komplikacije ovih infekcija. Cilj istraživanja je bio ispitivanje bakterijskih uzročnika i kliničkog toka bolničkih i vanbolničkih urinarnih infekcija kod bolesnika sa diabetes mellitusom. Metodi istraživanja: Ispitani su bolesnici sa diabetes mellitus-om lečeni zbog urinarnih infekcija na Odeljenju za infektivne bolesti Opšte bolnice Užice, od januara 2009. do decembra 2018. godine. Prikupljeni su epidemiološki, klinički, biohemijski i mikrobiološki podaci. Bakterijski uzročnici su dokazani zasejavanjem na standardne podloge za rast Gram pozitivnih i Gram negativnih bakterija. Rezultati: Od ukupno 772 bolesnika sa diabetes mellitusom koji su imali simptomatsku infekciju urinarnog trakta, kod 402 bolesnika urinarna infekcija je nastala u bolničkim uslovima. Od svih ispitanika, 67.7% su bile žene. Najčešći uzročnici urinarnih infekcija nastalih van bolnice bili su Escherichia coli, Klebsiella sp, Enterococcus (47%, 31%, 10%), a među bolničkim sojevima Klebsiella sp, Escherichia coli, Proteus mirabilis (41%, 32%, 9,7%). Komplikacije (sepsa, urinarna opstrukcija, pijelonefritis) su nastale kod 23.8% urinarnih infekcija nastalih van bolnice i kod 3,7% bolničkih infekcija. Plasiran urinarni kateter pre pojave infekcije imalo je 57.8% bolesnika, od čega 97,8% onih sa bolničkim poreklom urinarne infekcije. Zaključak: Najčešći uzročnici infekcije urinarnog trakta bolesnika sa dijabetesom su Escherichia coli i Klebsiella species, u bolničkim i
Introduction/Objective. A countrywide survey of venomous snakebites was never conducted in Serbia: the making of a central register was initiated only in 2018. We collected and analyzed the available data regarding venomous snakebites in the Uzice region (Western Serbia). The previous analysis from this hospital was published in 1968. Methods. We retrospectively analyzed the data regarding the venomous snakebite patients treated in the Uzice General Hospital between 2006 and 2018 and compared these with the data from the 1960s, from one more hospital in Serbia, and from two ex- Yugoslav countries. Results. In 13 years, 249 persons were treated. Of all cases, 10.4% were with inconspicuous symptoms (mild pain at the place of bite), 68.7% were with mild to moderate symptoms, and 20.9% were more or less severe. No fatalities were recorded. Conclusion. Although usually not a life-threatening issue, venomous snakebites are quite common and can cause serious complications. With proper education, many can be avoided. Also, bearing in mind not only the biodiversity per se but also the importance of snakes? venoms for the making of various medically important products, we emphasize the need for proper protection of all three venomous snake species in Serbia, namely Vipera ammodytes (nose-horned viper), V. berus (European adder), and V. ursinii (meadow viper).
Introduction: Influenza A H1N1 occurs worldwide sporadically or epidemically. There have been several epidemics of this disease in recent decades. Millions of people fell ill and hundreds of thousands died. The clinical picture varies from asymptomatic to lethal outcome. Older age, male gender and obesity are the most common risk factors for adverse disease. The aim of the research was to examine the clinical course and outcome of the disease of patients with pneumonia during the epidemic of influenza A H1N1 in 2019 in the Zlatibor district. Methods: Epidemiological, clinical, microbiological and radiographic data of patients with influenza A H1N1 treated at the Department of Infectious and Tropical Diseases and the Intensive Care Unit of the General Hospital of Uzice were retrogradely collected and analyzed. Virological and serological analyzes were performed at the Institute of Immunology and Virology "Torlak" in Belgrade. The diagnosis of acute respiratory distress syndrome (ARDS) was made according to the Berlin definition. Statistical analysis was performed using the Statistical Package for Social Sciences SPSS (version 16.0). Results: Out of a total of 274 patients, women accounted for 52.9%. The most common age was 61 to 70 years. 55.4% of patients had comorbidities, 61.8% of that had cardiovascular disease. C reactive protein was elevated in 79.2% of patients. Pneumonia confirmed by radiographic findings was present in 82.8% of patients, 51.5% of that had bilateral pneumonia. Four patients were pregnant, GML 5-9. Two of them had a mild clinical course of infection, one moderate with unilateral pneumonia. All three had a favorable disease outcome. A fourth pregnant woman was admitted in a severe clinical condition and was immediately referred to a tertiary health institution where the disease ended in death. 10.2% of patients were treated in the intensive care unit. Complications occurred in 23.7% of patients, ARDS in 52.3% of that. 55.9% of patients with ARDS were aged 61 to 70 years, and 58.8% were male. Among patients with ARDS, 94.1% had associated diseases, most often CVD (85.3%). C reactive protein was elevated in 85.3% of patients with ARDS. In 8.4% of patients, the disease had an unfavorable course and ended in death. Among these patients, 65.2% were women, and 73.9% were over 65 years of age. Associated diseases were present in 95.6% of these patients, cardiovascular diseases was present in 87% of that. Conclusion: During the influenza epidemic in 2019 in the Zlatibor district, pneumonia, most often bilateral, was most often in patients aged 61-70 with associated cardiovascular diseases. These were also the main risk factors for complications and adverse disease outcome. ARDS was the most common comlication and risk factor for the lethal outcome of the diseases.
Introduction: Fulminant hepatitis is a severe acute liver disease. It occurs due to massive necrosis of hepatocytes. The disease progresses to lethal outcome within a few days. The most common causes of this disease are toxic substances, autoimmune and viral hepatitis. The aim of the study was to present a lethal case of fulminant hepatitis caused by hepatitis B virus in a patient with treated bladder cancer. Case Outline: A 63-year-old patient was admitted for treatment due to weakness, nausea and decreased diuresis. She had surgery to remove her bladder, which was affected by a malignant process, two years earlier. On admission, she had a subicteric, orderly auscultatory finding. The abdomen was palpably painful below the right costal arch, without organomegaly. The ureterostomy was functional. The diagnosis of acute HBV infection was made by evidence of HBsAg, HBeAg and antiHBc IgM antibody titer. Laboratory findings indicated an increase in transaminases, urea, creatinine, total and conjugated bilirubin, decreased albumin values and coagulation disorders. The patient was treated with hepatoprotective therapy, antibiotics and antiviral therapy. Hemodialysis was performed as needed. Encephalopathy developed on the third day with further progression.The disease progressed with gastrointestinal bleeding and cardiac disorders and ended in death on the ninth day. Conclusion: Fulminant liver damage caused by hepatitis B virus is a severe disease that can be complicated by acute renal failure. The prognosis of the disease is often unfavorable, so optimal treatment requires a liver transplant.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.